|
FOREST LABS CL A, (FRX) Stock Research Free Stock Rating
|
|
| |
| Company Profile |
| |
|
Forest Laboratories, Inc. engages in the development, manufacture, and sale of prescription and non-prescription pharmaceutical products in the United States and the United Kingdom. The companys products include Lexapro, Celexa, Namenda, Tiazac, Benicar, Benicar HCT, Aerobid, Neramexane, Milnacipran, CCR1, Lercanidipine, and Acamprosate. The Lexapro and Celexa are used for the initial and maintenance treatment of depressive disorders, and for generalized anxiety disorders. The Namenda, an N-methyl-D-aspartate (NMDA)-receptor antagonist, is used for the treatment of moderate to severe Alzheimer's disease. The Tiazac, Benicar, Benicar HCT, and Lercanidipine are used for hypertension. The Aerobid, an inhaled steroid, is used for the treatment of asthma. The Neramexane, a NMDA receptor antagonist, is in Phase II clinical trials and is being tested for various CNS disorders. The Milnacipran is in Phase III development for the treatment of Fibromyalgia Syndrome. The CCR1 product is a chemokine receptor involved in the inflammation process. The Acamprosate is used for the treatment of alcohol dependence. The company markets its products to physicians, pharmacies, hospitals, managed care, and other healthcare organizations. Forest Laboratories was organized in 1956 and is headquartered in New York City, New York.
|
FOREST LABS CL A Related |
|
FRX: Summary for FOREST LABS CL A - Yahoo! Finance Get detailed information on FOREST LABS CL A (FRX) including quote performance, Real-Time ECN, technical chart analysis, key stats, insider transactions, and the ...
|
|
FRX: Profile for FOREST LABS CL A - Yahoo! Finance See the company profile for FOREST LABS CL A (FRX) including business summary, industry/sector information, number of employees, business summary, corporate ...
|
|
FRX: Summary for FOREST LABS CL A - Yahoo! Singapore Finance - Share ... FOREST LABS CL A - FRX - Summary, Chart, Share Price and further stock info ... FOREST LABS CL A (NYSE:FRX) Delayed quote data. Last Trade: 22.82 USD. Trade ...
|
|
